Too much of a good thing: Long-term treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity

Hearing Research

Volumn 265, Issue 1-2, 2010, Pages 63-69

  Chen, Guang Di ^a   Kermany, Mohammad Habiby ^a   D'Elia, Alessandra ^a,b   Ralli, Massimo ^a,c   Tanaka, Chiemi ^a   Bielefeld, Eric C ^a   Ding, Dalian ^a   Henderson, Donald ^a   Salvi, Richard ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF BARI   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PRESTIN; SALICYLIC ACID;

ACOUSTIC NERVE FIBER; ACTION POTENTIAL; AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL MOTILITY; CELL SURVIVAL; COCHLEA POTENTIAL; CONTROLLED STUDY; DRUG MEGADOSE; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; HEARING; NONHUMAN; OTOACOUSTIC EMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; TINNITUS;

ACOUSTIC STIMULATION; AGE FACTORS; AGING; ANIMALS; COCHLEAR MICROPHONIC POTENTIALS; COCHLEAR NERVE; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HAIR CELLS, AUDITORY, OUTER; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PRESBYCUSIS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SODIUM SALICYLATE; TINNITUS;

EID: 77952886003     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2010.02.010     Document Type: Article

References (81)

1. Althaus J.S., Andrus P.K., Williams C.M., VonVoigtlander P.F., Cazers A.R., Hall E.D. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F). Mol. Chem. Neuropathol. 1993, 20:147-162.
2. Bancroft B.R., Boettcher F.A., Salvi R.J., Wu J. Effects of noise and salicylate on auditory evoked-response thresholds in the chinchilla. Hear. Res. 1991, 54:20-28.
3. Bellosillo B., Pique M., Barragan M., Castano E., Villamor N., Colomer D., Montserrat E., Pons G., Gil J. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 1998, 92:1406-1414.
4. Bergman G.E., Philippidis P., Naiman J.L. Severe gastrointestinal hemorrhage and anemia after therapeutic doses of aspirin in normal children. J. Pediatr. 1976, 88:501-503.
5. Bernstein J.M., Weiss A.D. Further observations on salicylate ototoxicity. J. Laryngol. Otol. 1967, 81:915-925.
6. Bjorklund L., Wallander M.A., Johansson S., Lesen E. Aspirin in cardiology - benefits and risks. Int. J. Clin. Pract. 2009, 63:468-477.
7. Bosetti C., Gallus S., La Vecchia C. Aspirin and cancer risk: an update to 2001. Eur. J. Cancer Prev. 2002, 11:535-542.
8. Brandt C.T., Caye-Thomasen P., Lund S.P., Worsoe L., Ostergaard C., Frimodt-Moller N., Espersen F., Thomsen J., Lundgren J.D. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol. Dis. 2006, 23:300-311.
9. Butinar D., Starr A., Vatovec J. Brainstem auditory evoked potentials and cochlear microphonics in the HMSN family with auditory neuropathy. Pflugers Arch. 2000, 439:R204-R205.
10. Cazals Y. Auditory sensory-neural alterations induced by salicylate. Prog. Neurobiol. 2000, 62:583-631.
11. Cazals Y., Li X.Q., Aurousseau C., Didier A. Acute effects of noradrenalin related vasoactive agents on the ototoxicity of aspirin: an experimental study in the guinea pig. Hear. Res. 1988, 36:89-96.
12. Chen G.D., Li M., Tanaka C., Bielefeld E.C., Hu B.H., Kermany M.H., Salvi R., Henderson D. Aging outer hair cells (OHCs) in the Fischer 344 rat cochlea: function and morphology. Hear. Res. 2009, 248:39-47.
13. Chen Y., Huang W.G., Zha D.J., Qiu J.H., Wang J.L., Sha S.H., Schacht J. Aspirin attenuates gentamicin ototoxicity: from the laboratory to the clinic. Hear. Res. 2007, 226:178-182.
14. Danese C.A., Voleti C.D., Weiss H.J. Protection by aspirin against experimentally induced arterial thrombosis in dogs. Thromb. Diath. Haemorrh. 1971, 25:288-296.
15. Day R.O., Graham G.G., Bieri D., Brown M., Cairns D., Harris G., Hounsell J., Platt-Hepworth S., Reeve R., Sambrook P.N., et al. Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers. Br. J. Clin. Pharmacol. 1989, 28:695-702.
16. de Weck A.L., Gamboa P.M., Esparza R., Sanz M.L. Hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). Curr. Pharm. Des. 2006, 12:3347-3358.
17. Didier A., Miller J.M., Nuttall A.L. The vascular component of sodium salicylate ototoxicity in the guinea pig. Hear. Res. 1993, 69:199-206.
18. Falbe-Hansen J. Clinical and experimental histological studies of the effects of salicylates and quinine on the ear. Acta Otolaryngol. 1941, (Suppl. 44):1-216.
19. Gao W.Q. Role of neurotrophins and lectins in prevention of ototoxicity. Ann. N. Y. Acad. Sci. 1999, 884:312-327.
20. Gibson C.D., Towson I.G. Case report: acute allergic reaction to aspirin. J. Med. Assoc. Ga. 1956, 45:366.
21. Gold A., Wilpizeski C.R. Studies in auditory adaptation. II. Some effects of sodium salicylate on evoked auditory potentials in cats. Laryngoscope 1966, 76:674-685.
22. Guitton M.J., Caston J., Ruel J., Johnson R.M., Pujol R., Puel J.L. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J. Neurosci. 2003, 23:3944-3952.
23. Gunther T., Rebentisch E., Vormann J. Protection against salicylate ototoxicity by zinc. J. Trace Elem. Electrolytes Health Dis. 1989, 3:51-53.
24. Gunther T., Rebentisch E., Vormann J., Konig M., Ising H. Enhanced ototoxicity of gentamicin and salicylate caused by Mg deficiency and Zn deficiency. Biol. Trace Elem. Res. 1988, 16:43-50.
25. Huang Z.W., Luo Y., Wu Z., Tao Z., Jones R.O., Zhao H.B. Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate. J. Neurophysiol. 2005, 93:2053-2061.
26. Jacobs E.J., Rodriguez C., Mondul A.M., Connell C.J., Henley S.J., Calle E.E., Thun M.J. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J. Natl. Cancer Inst. 2005, 97:975-980.
27. Jager B.V., Alway R. The treatment of acute rheumatic fever with large doses of sodium salicylate. Am. J. Med. Sci. 1946, 211:273-285.
28. Janssen T., Boege P., Oestreicher E., Arnold W. Tinnitus and 2f1-f2 distortion product otoacoustic emissions following salicylate overdose. J. Acoust. Soc. Am. 2000, 107:1790-1792.
29. Jastreboff P.J., Brennan J.F., Sasaki C.T. An animal model for tinnitus. Laryngoscope 1988, 98:280-286.
30. Jastreboff P.J., Hansen R., Sasaki P.G., Sasaki C.T. Differential uptake of salicylate in serum, cerebrospinal fluid, and perilymph. Arch. Otolaryngol. Head Neck Surg. 1986, 112:1050-1053.
31. Jastreboff P.J., Issing W., Brennan J.F., Sasaki C.T. Pigmentation, anesthesia, behavioral factors, and salicylate uptake. Arch. Otolaryngol. Head Neck Surg. 1988, 114:186-191.
32. Johnsen N.J., Elberling C. Evoked acoustic emissions from the human ear. I. Equipment and response parameters. Scand. Audiol. 1982, 11:3-12.
33. Kojda G. Direct vasoprotection by aspirin: a significant bonus to antiplatelet activity?. Cardiovasc. Res. 2004, 64:192-194.
34. Kopke R.D., Weisskopf P.A., Boone J.L., Jackson R.L., Wester D.C., Hoffer M.E., Lambert D.C., Charon C.C., Ding D.L., McBride D. Reduction of noise-induced hearing loss using L-NAC and salicylate in the chinchilla. Hear. Res. 2000, 149:138-146.
35. Kujawa S.G., Liberman M.C. Adding insult to injury: cochlear nerve degeneration after " temporary" noise-induced hearing loss. J. Neurosci. 2009, 29:14077-14085.
36. Lambert P.R., Palmer P.E., Rubel E.W. The interaction of noise and aspirin in the chick basilar papilla. Noise and aspirin toxicity. Arch. Otolaryngol. Head. Neck Surg. 1986, 112:1043-1049.
37. Laska E.M., Sunshine A., Wanderling J.A., Meisner M.J. Quantitative differences in aspirin analgesia in three models of clinical pain. J. Clin. Pharmacol. 1982, 22:531-542.
38. Lee E.J., Park H.G., Kang H.S. Sodium salicylate induces apoptosis in HCT116 colorectal cancer cells through activation of p38MAPK. Int. J. Oncol. 2003, 23:503-508.
39. Li G., Sha S.H., Zotova E., Arezzo J., Van de Water T., Schacht J. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab. Invest. 2002, 82:585-596.
40. McCabe P.A., Dey F.L. The effect of aspirin upon auditory sensitivity. Ann Otol. Rhinol. Laryngol. 1965, 74:312-325.
41. McFadden D., Plattsmier H.S., Pasanen E.G. Aspirin-induced hearing loss as a model of sensorineural hearing loss. Hear. Res. 1984, 16:251-260.
42. McFadden D., Plattsmier H.S., Pasanen E.G. Temporary hearing loss induced by combinations of intense sounds and nonsteroidal anti-inflammatory drugs. Am. J. Otolaryngol. 1984, 5:235-241.
43. Mitchell C., Brummett R., Himes D., Vernon J. Electrophysiological study of the effect of sodium salicylate upon the cochlea. Arch. Otolaryngol. 1973, 98:297-301.
44. Myers E.N., Bernstein J.M. Salicylate ototoxicity; a clinical and experimental study. Arch. Otolaryngol. 1965, 82:483-493.
45. Myers E.N., Bernstein J.M., Fostiropolous G. Salicylate ototoxicity: a clinical study. N. Engl. J. Med. 1965, 273:587-590.
46. Nunez L., Gil Aguado M., Larrea J.L., Celemin D., Oliver J. Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis. Ann. Thorac. Surg. 1984, 37:84-87.
47. Oh K.W., Qian T., Brenner D.A., Lemasters J.J. Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition. Toxicol. Sci. 2003, 73:44-52.
48. Oh S.Y., Kim J.H., Park M.J., Kim S.M., Yoon C.S., Joo Y.M., Park J.S., Han S.I., Park H.G., Kang H.S. Induction of heat shock protein 72 in C6 glioma cells by methyl jasmonate through ROS-dependent heat shock factor 1 activation. Int. J. Mol. Med. 2005, 16:833-839.
49. Oliveira J.A., Marseillan R.F. Toxicity of sodium salicylate on the guinea-pig labyrinth. Rev. Laryngol. Otol. Rhinol (Bord) 1976, 97:17-21.
50. Oliver D., He D.Z., Klocker N., Ludwig J., Schulte U., Waldegger S., Ruppersberg J.P., Dallos P., Fakler B. Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein. Science 2001, 292:2340-2343.
51. Oudot J., Pignat J.C., Martin H. Acute aspirin poisoning and deafness. Apropos of 10 cases. J. Fr. Otorhinolaryngol. Audiophonol. Chir. Maxillofac. 1979, 28:687-693.
52. Perez de Moura L.F., Hayden R.C. Salicylate ototoxicity. A human temporal bone report. Arch. Otolaryngol. 1968, 87:368-372.
53. Perlman L.V. Salicylate intoxication from skin application. N. Engl. J. Med. 1966, 274:164.
54. Ramsden R.T., Latif A., O'Malley S. Electrocochleographic changes in acute salicylate overdosage. J. Laryngol. Otol. 1985, 99:1269-1273.
55. Ruel J., Chabbert C., Nouvian R., Bendris R., Eybalin M., Leger C.L., Bourien J., Mersel M., Puel J.L. Salicylate enables cochlear arachidonic-acid-sensitive NMDA receptor responses. J. Neurosci. 2008, 28:7313-7323.
56. Rupp D.J., Seaton R.D., Wiegmann T.B. Acute polyuric renal failure after aspirin intoxication. Arch. Intern. Med. 1983, 143:1237-1238.
57. Saltzman D.A., Gall E.P., Robinson S.F. Aspirin-induced hepatic dysfunction in a patient with adult rheumatoid arthritis. Am. J. Dig. Dis. 1976, 21:815-820.
58. Schuknecht H.F. Auditory and cytocochlear correlates of inner ear disorders. Otolaryngol. Head Neck Surg. 1994, 110:530-538.
59. Schuknecht H.F., Mikaelian D.O., Wanfield D. Partial eighth nerve section. Arch. Otolaryngol. 1971, 93:541-542.
60. Schwenger P., Bellosta P., Vietor I., Basilico C., Skolnik E.Y., Vilcek J. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc. Natl. Acad. Sci. USA 1997, 94:2869-2873.
61. Seo M.S., Oh S.Y., Park M.J., Kim S.M., Kim M.Y., Han S.I., Park H.G., Kang H.S. Implication of reactive oxygen species, ERK1/2, and p38MAPK in sodium salicylate-induced heat shock protein 72 expression in C6 glioma cells. Int. J. Mol. Med. 2005, 16:841-849.
62. Sha S.H., Schacht J. Salicylate attenuates gentamicin-induced ototoxicity. Lab. Invest. 1999, 79:807-813.
63. Sha S.H., Qiu J.H., Schacht J. Aspirin to prevent gentamicin-induced hearing loss. N. Engl. J. Med. 2006, 354:1856-1857.
64. Silverstein H., Bernstein J.M., Davies D.G. Salicylate ototoxicity. A biochemical and electrophysiological study. Ann. Otol. Rhinol. Laryngol. 1967, 76:118-128.
65. Skjelbred P. The effects of acetylsalicylic acid on swelling, pain and other events after surgery. Br. J. Clin. Pharmacol. 1984, 17:379-384.
66. Speir E., Yu Z.X., Ferrans V.J., Huang E.S., Epstein S.E. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res. 1998, 83:210-216.
67. Spongr V.P., Boettcher F.A., Saunders S.S., Salvi R.J. Effects of noise and salicylate on hair cell loss in the chinchilla cochlea. Arch. Otolaryngol. Head Neck Surg. 1992, 118:157-164.
68. Starr A., Picton T.W., Sininger Y., Hood L.J., Berlin C.I. Auditory neuropathy. Brain 1996, 119(Pt. 3):741-753.
69. Stypulkowski P.H. Mechanisms of salicylate ototoxicity. Hear. Res. 1990, 46:113-145.
70. Thalmann R., Miyoshi T., Kusakari J., Thalmann I. Quantitative approaches to the ototoxicity problem. Audiology 1973, 12:364-382.
71. Thomas J., Straus W.L., Bloom B.S. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Am. J. Gastroenterol. 2002, 97:2215-2219.
72. Tigerstedt I., Leander P., Tammisto T. Postoperative analgesics for superficial surgery. Comparison of four analgesics. Acta Anaesthesiol. Scand. 1981, 25:543-547.
73. Waltner J.G. The effect of salicylates on the inner ear. Ann. Otol. Rhinol. Laryngol. 1955, 64:617-622.
74. Wecker H., Laubert A. Reversible hearing loss in acute salicylate intoxication. HNO 2004, 52:347-351.
75. Wei L. Degeneration of Cochlear SGNs Caused by Salicylate 2009, University at Buffalo, Buffalo.
76. Woodford C.M., Henderson D., Hamernik R.P. Effects of combinations of sodium salicylate and noise on the auditory threshold. Ann. Otol. Rhinol. Laryngol. 1978, 87:117-127.
77. Yamashita D., Jiang H.Y., Le Prell C.G., Schacht J., Miller J.M. Post-exposure treatment attenuates noise-induced hearing loss. Neuroscience 2005, 134:633-642.
78. Yang K., Huang Z.W., Liu Z.Q., Xiao B.K., Peng J.H. Long-term administration of salicylate enhances prestin expression in rat cochlea. Int. J. Audiol. 2009, 48:18-23.
79. Yiannakopoulou E., Tiligada E. Protective effect of salicylates against hydrogen peroxide stress in yeast. J. Appl. Microbiol. 2009, 106:903-908.
80. Yu N., Zhu M.L., Johnson B., Liu Y.P., Jones R.O., Zhao H.B. Prestin up-regulation in chronic salicylate (aspirin) administration: an implication of functional dependence of prestin expression. Cell. Mol. Life Sci. 2008, 65:2407-2418.
81. Zucker P., Daum F., Cohen M.I. Aspirin hepatitis. Am. J. Dis. Child 1975, 129:1433-1434.